Pierce David A
CIK 0001529751 Name as filed on the most recent filing
Filed as Pierce David A (86)
89 transaction lines · from 86 filings · filed 2011-11-08 to 2022-03-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
89 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2022-03-01 |
Boston Scientific Corp BSX |
S, Open-market sale | 1,726 disposed | 43.94 | 75,840.44 | Form 4, filing 0001225208-22-003867 | |
| 2022-02-23 |
Boston Scientific Corp BSX |
S, Open-market sale | 1,761 disposed | 43.28 | 76,216.08 | Form 4, filing 0001225208-22-003299 | |
| 2022-02-22 |
Boston Scientific Corp BSX |
S, Open-market sale | 1,884 disposed | 42.55 | 80,164.20 | Form 4, filing 0001225208-22-003299 | |
| 2022-02-18 |
Boston Scientific Corp BSX |
S, Open-market sale | 2,354 disposed | 42.88 | 100,939.52 | Form 4, filing 0001225208-22-002932 | |
| 2022-02-16 |
Boston Scientific Corp BSX |
S, Open-market sale | 1,956 disposed | 43.81 | 85,692.36 | Form 4, filing 0001225208-22-002694 | |
| 2022-01-04 |
Boston Scientific Corp BSX |
S, Open-market sale | 6,161 disposed | 43.54 | 268,229.61 | Form 4, filing 0001225208-22-000470 | |
| 2021-12-20 |
Boston Scientific Corp BSX |
S, Open-market sale | 49,988 disposed | 39.90 | 1,994,621.18 | Form 4, filing 0001225208-21-015180 | |
| 2021-06-03 |
Boston Scientific Corp BSX |
S, Open-market sale | 1,654 disposed | 41.36 | 68,409.44 | Form 4, filing 0001225208-21-009034 | |
| 2021-03-16 |
Boston Scientific Corp BSX |
S, Open-market sale | 7,603 disposed | 39.36 | 299,245.72 | Form 4, filing 0001225208-21-005427 | |
| 2021-03-02 |
Boston Scientific Corp BSX |
S, Open-market sale | 1,360 disposed | 38.90 | 52,904.00 | Form 4, filing 0001225208-21-004699 | |
| 2021-02-23 |
Boston Scientific Corp BSX |
S, Open-market sale | 2,836 disposed | 39.20 | 111,171.20 | Form 4, filing 0001225208-21-003606 | |
| 2021-02-19 |
Boston Scientific Corp BSX |
S, Open-market sale | 1,484 disposed | 38.00 | 56,392.00 | Form 4, filing 0001225208-21-003526 | |
| 2021-02-16 |
Boston Scientific Corp BSX |
S, Open-market sale | 1,540 disposed | 38.28 | 58,951.20 | Form 4, filing 0001225208-21-002709 | |
| 2021-02-04 |
Boston Scientific Corp BSX |
S, Open-market sale | 11,317 disposed | 38.00 | 430,046.00 | Form 4, filing 0001225208-21-001881 | |
| 2020-11-09 |
Boston Scientific Corp BSX |
S, Open-market sale | 2,028 disposed | 39.00 | 79,092.00 | Form 4, filing 0001225208-20-013294 | |
| 2020-10-01 |
Boston Scientific Corp BSX |
S, Open-market sale | 2,282 disposed | 38.56 | 87,993.92 | Form 4, filing 0001225208-20-012181 | |
| 2020-09-01 |
Boston Scientific Corp BSX |
S, Open-market sale | 2,044 disposed | 40.70 | 83,190.80 | Form 4, filing 0001225208-20-011201 | |
| 2020-08-03 |
Boston Scientific Corp BSX |
S, Open-market sale | 2,385 disposed | 38.69 | 92,275.65 | Form 4, filing 0001225208-20-010202 | |
| 2020-07-22 |
Boston Scientific Corp BSX |
S, Open-market sale | 2,170 disposed | 38.00 | 82,460.00 | Form 4, filing 0001225208-20-009906 | |
| 2020-06-03 |
Boston Scientific Corp BSX |
S, Open-market sale | 1,624 disposed | 38.00 | 61,712.00 | Form 4, filing 0001225208-20-008638 | |
| 2020-06-01 |
Boston Scientific Corp BSX |
S, Open-market sale | 1,969 disposed | 38.00 | 74,822.00 | Form 4, filing 0001225208-20-008565 | |
| 2020-05-08 |
Boston Scientific Corp BSX |
S, Open-market sale | 2,057 disposed | 38.00 | 78,166.00 | Form 4, filing 0001225208-20-007407 | |
| 2020-04-17 |
Boston Scientific Corp BSX |
S, Open-market sale | 14,793 disposed | 38.00 | 562,134.00 | Form 4, filing 0001225208-20-006612 | |
| 2020-03-02 |
Boston Scientific Corp BSX |
S, Open-market sale | 3,485 disposed | 38.00 | 132,430.00 | Form 4, filing 0001225208-20-004164 | |
| 2020-02-25 |
Boston Scientific Corp BSX |
S, Open-market sale | 4,122 disposed | 41.15 | 169,620.30 | Form 4, filing 0001225208-20-003570 | |
| 2020-02-19 |
Boston Scientific Corp BSX |
S, Open-market sale | 1,511 disposed | 42.31 | 63,930.41 | Form 4, filing 0001225208-20-002842 | |
| 2020-02-03 |
Boston Scientific Corp BSX |
S, Open-market sale | 2,150 disposed | 42.17 | 90,665.50 | Form 4, filing 0001225208-20-001555 | |
| 2020-01-03 |
Boston Scientific Corp BSX |
S, Open-market sale | 8,270 disposed | 44.73 | 369,944.39 | Form 4, filing 0001225208-20-000516 | |
| 2020-01-02 |
Boston Scientific Corp BSX |
S, Open-market sale | 2,152 disposed | 45.50 | 97,916.00 | Form 4, filing 0001225208-20-000300 | |
| 2019-12-02 |
Boston Scientific Corp BSX |
S, Open-market sale | 5,000 disposed | 43.33 | 216,650.00 | Form 4, filing 0001225208-19-015213 | |
| 2019-11-01 |
Boston Scientific Corp BSX |
S, Open-market sale | 5,000 disposed | 42.05 | 210,250.00 | Form 4, filing 0001225208-19-014049 | |
| 2019-10-01 |
Boston Scientific Corp BSX |
S, Open-market sale | 5,000 disposed | 41.14 | 205,685.50 | Form 4, filing 0001225208-19-013150 | |
| 2019-09-03 |
Boston Scientific Corp BSX |
S, Open-market sale | 5,000 disposed | 42.50 | 212,500.00 | Form 4, filing 0001225208-19-012123 | |
| 2019-08-02 |
Boston Scientific Corp BSX |
S, Open-market sale | 5,000 disposed | 42.62 | 213,091.50 | Form 4, filing 0001225208-19-010843 | |
| 2019-07-01 |
Boston Scientific Corp BSX |
S, Open-market sale | 5,000 disposed | 43.41 | 217,050.00 | Form 4, filing 0001225208-19-009811 | |
| 2019-06-04 |
Boston Scientific Corp BSX |
S, Open-market sale | 1,650 disposed | 38.60 | 63,684.06 | Form 4, filing 0001225208-19-008887 | |
| 2019-06-03 |
Boston Scientific Corp BSX |
S, Open-market sale | 5,140 disposed | 38.45 | 197,650.48 | Form 4, filing 0001225208-19-008775 | |
| 2019-05-01 |
Boston Scientific Corp BSX |
S, Open-market sale | 5,000 disposed | 37.10 | 185,500.00 | Form 4, filing 0001225208-19-007570 | |
| 2019-04-01 |
Boston Scientific Corp BSX |
S, Open-market sale | 5,000 disposed | 38.82 | 194,100.00 | Form 4, filing 0001225208-19-006107 | |
| 2019-03-18 |
Boston Scientific Corp BSX |
S, Open-market sale | 14,400 disposed | 39.12 | 563,263.20 | Form 4, filing 0001225208-19-005485 | |
| 2019-03-18 |
Boston Scientific Corp BSX |
S, Open-market sale | 339 disposed | 39.82 | 13,498.98 | Form 4, filing 0001225208-19-005485 | |
| 2019-03-06 |
Boston Scientific Corp BSX |
S, Open-market sale | 1,357 disposed | 40.25 | 54,619.25 | Form 4, filing 0001225208-19-004892 | |
| 2019-03-01 |
Boston Scientific Corp BSX |
S, Open-market sale | 5,000 disposed | 40.34 | 201,679.00 | Form 4, filing 0001225208-19-004351 | |
| 2019-02-26 |
Boston Scientific Corp BSX |
S, Open-market sale | 4,508 disposed | 39.83 | 179,561.30 | Form 4, filing 0001225208-19-003856 | |
| 2019-02-20 |
Boston Scientific Corp BSX |
S, Open-market sale | 1,952 disposed | 39.86 | 77,806.72 | Form 4, filing 0001225208-19-003444 | |
| 2019-02-01 |
Boston Scientific Corp BSX |
S, Open-market sale | 5,000 disposed | 38.15 | 190,750.00 | Form 4, filing 0001225208-19-001825 | |
| 2019-01-09 |
Boston Scientific Corp BSX |
S, Open-market sale | 10,319 disposed | 35.67 | 368,078.73 | Form 4, filing 0001225208-19-000804 | |
| 2019-01-08 |
Boston Scientific Corp BSX |
S, Open-market sale | 5,000 disposed | 35.00 | 175,000.00 | Form 4, filing 0001225208-19-000771 | |
| 2018-12-03 |
Boston Scientific Corp BSX |
S, Open-market sale | 5,000 disposed | 38.11 | 190,574.00 | Form 4, filing 0001225208-18-016172 | |
| 2018-11-01 |
Boston Scientific Corp BSX |
S, Open-market sale | 5,000 disposed | 36.40 | 181,975.50 | Form 4, filing 0001225208-18-015121 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 89
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Pierce David A, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001529751
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6